BioDuro, a China-US CRO, has merged its US operations with Formex, an API formulation, development and cGMP manufacturing company located in San Diego. Both companies are owned by Bridgewest Group of San Diego. In July, Bridgewest bought BioDuro from PPD, a global CRO. Masood Tayebi, PhD, who is a Partner and CEO of Bridgewest, founded BioDuro in 2005, sold it to PPD in 2012, re-acquired the company, and now he has merged Formex, another Bridgewest biopharma investment, into BioDuro.
Help employers find you! Check out all the jobs and post your resume.
